Ekso Bionics Holding (EKSO) 2.8300 $EKSO
Ekso Bionics to Report First Quarter 2014 Financial Results on Thursday, May 8, 2014
GlobeNewswire - Fri May 02, 6:00AM CDT
Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, today announced that it will hold a conference call and audio webcast to discuss financial results for its first quarter 2014 and provide a general business update on Thursday, May 8, 2014 at 4:30pm ET.
Ekso Bionics(TM) CEO Nathan Harding to Be Interviewed Live Today on Bloomberg Television's "Taking Stock with Pimm Fox"
GlobeNewswire - Wed Apr 30, 2:42PM CDT
Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton pioneer, today announced that CEO Nathan Harding will be interviewed live today by host Pimm Fox on Bloomberg Television's Taking Stock with Pimm Fox. Any interested parties may tune in and listen live via Bloomberg Television's live stream: http://www.bloomberg.com/tv/
CytoSorbents Corp. Expands Its Product Distribution to Include the Middle East
ACCESSWIRE - Fri Apr 25, 8:51AM CDT
CytoSorbents Corp.'s (OTCQB: CTSO) stock volume surged Apr. 24, with 1,774,353 shares changing hands, higher than its three-month average volume of 1,703,870 shares.
SoldierSocks Foundation Donates Ekso Bionics(TM) Suit to VA Boston Healthcare System
GlobeNewswire - Thu Apr 24, 6:02AM CDT
SoldierSocks, a non-profit foundation focused on helping veterans, announced today that VA Boston Healthcare System (West Roxbury campus) is the next recipient of an Ekso Bionics(TM) suit (OTCQB:EKSO). The Ekso GT(TM) will help injured veterans walk again. VA Boston serves over 500 paralyzed veterans in the northeast region and will accept the suit in a donation ceremony on April 30, 2014 at 9:30 am with a special appearance from SoldierSocks' first Ekso recipient, veteran Dan Rose who will walk in an Ekso device.
Kessler Foundation Selects Ekso GT(TM) for Pilot Study on Robotics in Mobility
GlobeNewswire - Thu Apr 10, 6:00AM CDT
Research to Focus on Neuro-Rehabilitation and Gait Training Among Stroke Population
Ekso Bionics(TM) Announces Launch of Ekso(TM) Labs
GlobeNewswire - Fri Mar 28, 6:00AM CDT
Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, announced today that co-founder Russ Angold was named president of the company's division focused on technology development and future applications, formally named Ekso Labs. Russ will oversee and build out the division that is responsible for developing intellectual property through engineering contracts and research grants from government organizations and industrial partners, including the Department of Defense (DOD). Ekso Bionics has a long history of engineering services work creating an important intellectual property portfolio dating back to the company's inception in 2005.
Ekso Bionics CEO Nathan Harding to Be Interviewed Live Today on Clear Channel Business Talk Radio
Marketwire - Wed Mar 26, 7:45AM CDT
Ekso Bionics Holdings, Inc. (OTCQB: EKSO), a robotic exoskeleton pioneer, today announced that CEO Nathan Harding will be interviewed live today by host Michael Yorba on Clear Channel Business Talk Radio's The Traders Network Show. Any interested parties may tune in and listen live via Clear Channel's nationally syndicated iHeart Radio stream.
General Electric Signs $400 Million Algerian Agreement; Growlife and Vape Holdings Enter Joint Venture
ACCESSWIRE - Wed Mar 19, 11:30PM CDT
General Electric Company (NYSE: GE) - For an in-depth report on General Electric Company follow: www.BullTrends.com/stockquote/GE
Ekso Bionics(TM) Expands Executive Team
GlobeNewswire - Mon Mar 10, 5:58PM CDT
Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton pioneer, announced today that Glenn Davis and Thomas Looby have joined the company to amplify its sales and marketing strategies. Davis brings over 20 years of sales experience with Siemens Healthcare and a comprehensive understanding of how to drive revenue within the Healthcare Sector in major and emerging markets while Looby adds his experience in systematically driving adoption of novel, high tech solutions to critical healthcare problems, most recently with Given Imaging. Both Davis and Looby have considerable experience in medical device market development and will work in tandem to build a robust business for Ekso Bionics.
3D Systems and Ekso Bionics(TM) Announce First "Bespoke" Exoskeleton
GlobeNewswire - Wed Feb 19, 5:33PM CST
Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, today announced that it recently debuted the first ever 3D printed hybrid exoskeleton robotic suit, in collaboration with 3D Systems (NYSE
DD), at a Singularity University event in Budapest. Designers from 3D Systems created personalized three-dimensional elements from multiple 3D scans taken of Ekso Ambassador, Amanda Boxtel.
RE2, Inc. Awarded Contract to Develop Exoskeleton Simulator
Marketwire - Wed Feb 19, 7:03AM CST
RE2, Inc. announced today that the company has been awarded a Phase I Small Business Innovation Research (SBIR) program with the U.S. Army to develop the Biomechanical Exoskeleton Simulator System, a software tool to assess the impact of load carriage and body-wearable robotic devices on musculoskeletal health and performance. RE2 is partnering with biomechanical exoskeleton experts at Ekso Bionics(TM) (OTCBB: EKSO) and neuromusculoskeletal simulation leader, Dr. Scott Delp, faculty at Stanford University.
Ekso Bionics(TM) Named One of "5 Startups Poised to Change MedTech Forever"
GlobeNewswire - Thu Feb 13, 4:00PM CST
Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, today announced that it was named one of five startups poised to change MedTech forever by Medical Device & Diagnostic Industry Magazine. MD+DI 's editorial quality and reliability has won it an unparalleled degree of trust from the industry. For more than 30 years, MD+DI has served the industry as the leading source of in-depth news and information; many of their articles have become standards of reference for the medical device industry.
Robotics Maker Ekso Aims to Help Wheelchair-Bound to Walk
at The Street - Fri Feb 07, 11:24AM CST
The newly public company has raised $20.6 million in new capital to develop and sell its technology.
Ekso Bionics(TM) Completes Private Placement, Raising $30.3M
GlobeNewswire - Thu Feb 06, 7:01PM CST
Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, today announced that it completed its private placement offering as part of its January 15, 2014 announced alternative public offering ("APO"
. Shares of the Company's common stock are currently quoted on the OTC Markets under the symbol "EKSO."
Robotic Exoskeleton Innovator Ekso Bionics(TM) Goes Public, Raises $20.6M
GlobeNewswire - Wed Jan 15, 4:11PM CST
via PRWEB - Ekso Bionics Holdings, Inc. (formerly PN Med Group, Inc.) (OTCBB:EKSO), a Nevada corporation (the "Company" , announced today that it completed an alternative public offering on January 15, 2014, in which Ekso Bionics, Inc., a Delaware corporation ("Ekso Bionics" , became a wholly owned subsidiary of the Company, and completed a simultaneous $20.6 million private placement offering. Shares of the Company's common stock are currently quoted on the OTC Markets under the symbol "EKSO."
Ekso Bionics to Report First Quarter 2014 Financial Results on Thursday, May 8, 2014
GlobeNewswire - Fri May 02, 6:00AM CDT
Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, today announced that it will hold a conference call and audio webcast to discuss financial results for its first quarter 2014 and provide a general business update on Thursday, May 8, 2014 at 4:30pm ET.
Ekso Bionics(TM) CEO Nathan Harding to Be Interviewed Live Today on Bloomberg Television's "Taking Stock with Pimm Fox"
GlobeNewswire - Wed Apr 30, 2:42PM CDT
Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton pioneer, today announced that CEO Nathan Harding will be interviewed live today by host Pimm Fox on Bloomberg Television's Taking Stock with Pimm Fox. Any interested parties may tune in and listen live via Bloomberg Television's live stream: http://www.bloomberg.com/tv/
CytoSorbents Corp. Expands Its Product Distribution to Include the Middle East
ACCESSWIRE - Fri Apr 25, 8:51AM CDT
CytoSorbents Corp.'s (OTCQB: CTSO) stock volume surged Apr. 24, with 1,774,353 shares changing hands, higher than its three-month average volume of 1,703,870 shares.
SoldierSocks Foundation Donates Ekso Bionics(TM) Suit to VA Boston Healthcare System
GlobeNewswire - Thu Apr 24, 6:02AM CDT
SoldierSocks, a non-profit foundation focused on helping veterans, announced today that VA Boston Healthcare System (West Roxbury campus) is the next recipient of an Ekso Bionics(TM) suit (OTCQB:EKSO). The Ekso GT(TM) will help injured veterans walk again. VA Boston serves over 500 paralyzed veterans in the northeast region and will accept the suit in a donation ceremony on April 30, 2014 at 9:30 am with a special appearance from SoldierSocks' first Ekso recipient, veteran Dan Rose who will walk in an Ekso device.
Kessler Foundation Selects Ekso GT(TM) for Pilot Study on Robotics in Mobility
GlobeNewswire - Thu Apr 10, 6:00AM CDT
Research to Focus on Neuro-Rehabilitation and Gait Training Among Stroke Population
Ekso Bionics(TM) Announces Launch of Ekso(TM) Labs
GlobeNewswire - Fri Mar 28, 6:00AM CDT
Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, announced today that co-founder Russ Angold was named president of the company's division focused on technology development and future applications, formally named Ekso Labs. Russ will oversee and build out the division that is responsible for developing intellectual property through engineering contracts and research grants from government organizations and industrial partners, including the Department of Defense (DOD). Ekso Bionics has a long history of engineering services work creating an important intellectual property portfolio dating back to the company's inception in 2005.
Ekso Bionics CEO Nathan Harding to Be Interviewed Live Today on Clear Channel Business Talk Radio
Marketwire - Wed Mar 26, 7:45AM CDT
Ekso Bionics Holdings, Inc. (OTCQB: EKSO), a robotic exoskeleton pioneer, today announced that CEO Nathan Harding will be interviewed live today by host Michael Yorba on Clear Channel Business Talk Radio's The Traders Network Show. Any interested parties may tune in and listen live via Clear Channel's nationally syndicated iHeart Radio stream.
General Electric Signs $400 Million Algerian Agreement; Growlife and Vape Holdings Enter Joint Venture
ACCESSWIRE - Wed Mar 19, 11:30PM CDT
General Electric Company (NYSE: GE) - For an in-depth report on General Electric Company follow: www.BullTrends.com/stockquote/GE
Ekso Bionics(TM) Expands Executive Team
GlobeNewswire - Mon Mar 10, 5:58PM CDT
Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton pioneer, announced today that Glenn Davis and Thomas Looby have joined the company to amplify its sales and marketing strategies. Davis brings over 20 years of sales experience with Siemens Healthcare and a comprehensive understanding of how to drive revenue within the Healthcare Sector in major and emerging markets while Looby adds his experience in systematically driving adoption of novel, high tech solutions to critical healthcare problems, most recently with Given Imaging. Both Davis and Looby have considerable experience in medical device market development and will work in tandem to build a robust business for Ekso Bionics.
3D Systems and Ekso Bionics(TM) Announce First "Bespoke" Exoskeleton
GlobeNewswire - Wed Feb 19, 5:33PM CST
Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, today announced that it recently debuted the first ever 3D printed hybrid exoskeleton robotic suit, in collaboration with 3D Systems (NYSE
DD), at a Singularity University event in Budapest. Designers from 3D Systems created personalized three-dimensional elements from multiple 3D scans taken of Ekso Ambassador, Amanda Boxtel. RE2, Inc. Awarded Contract to Develop Exoskeleton Simulator
Marketwire - Wed Feb 19, 7:03AM CST
RE2, Inc. announced today that the company has been awarded a Phase I Small Business Innovation Research (SBIR) program with the U.S. Army to develop the Biomechanical Exoskeleton Simulator System, a software tool to assess the impact of load carriage and body-wearable robotic devices on musculoskeletal health and performance. RE2 is partnering with biomechanical exoskeleton experts at Ekso Bionics(TM) (OTCBB: EKSO) and neuromusculoskeletal simulation leader, Dr. Scott Delp, faculty at Stanford University.
Ekso Bionics(TM) Named One of "5 Startups Poised to Change MedTech Forever"
GlobeNewswire - Thu Feb 13, 4:00PM CST
Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, today announced that it was named one of five startups poised to change MedTech forever by Medical Device & Diagnostic Industry Magazine. MD+DI 's editorial quality and reliability has won it an unparalleled degree of trust from the industry. For more than 30 years, MD+DI has served the industry as the leading source of in-depth news and information; many of their articles have become standards of reference for the medical device industry.
Robotics Maker Ekso Aims to Help Wheelchair-Bound to Walk
at The Street - Fri Feb 07, 11:24AM CST
The newly public company has raised $20.6 million in new capital to develop and sell its technology.
Ekso Bionics(TM) Completes Private Placement, Raising $30.3M
GlobeNewswire - Thu Feb 06, 7:01PM CST
Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, today announced that it completed its private placement offering as part of its January 15, 2014 announced alternative public offering ("APO"
. Shares of the Company's common stock are currently quoted on the OTC Markets under the symbol "EKSO." Robotic Exoskeleton Innovator Ekso Bionics(TM) Goes Public, Raises $20.6M
GlobeNewswire - Wed Jan 15, 4:11PM CST
via PRWEB - Ekso Bionics Holdings, Inc. (formerly PN Med Group, Inc.) (OTCBB:EKSO), a Nevada corporation (the "Company"
, announced today that it completed an alternative public offering on January 15, 2014, in which Ekso Bionics, Inc., a Delaware corporation ("Ekso Bionics" , became a wholly owned subsidiary of the Company, and completed a simultaneous $20.6 million private placement offering. Shares of the Company's common stock are currently quoted on the OTC Markets under the symbol "EKSO." 
